Search results for: liver

Measuring Quality of Care Is Here to Stay—and the ACR Can Help

Staff | January 1, 2009

Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.

ACR’s Premier Learning Venue

Sherine Gabriel, MD | January 1, 2009

Annual Scientific Meeting no longer an endurance sport

Drug Updates

Michele B. Kaufman, PharmD, BCGP | January 1, 2009

Information on safety, labeling changes, and pharmaceutical research

Patient Self-Management Pioneer

Gretchen Henkel | December 1, 2008

Kate Lorig RN, DrPH, continues to map new territories

A New Breed of Practice

From the College | December 1, 2008

As small practice physicians are forced to combat increasing overhead and shriveling reimbursement, we seem to be entering an era of medical practice Darwinism—survival of those that are most fit to operate in today’s severe and unforgiving healthcare environment.

Quality Advice from Specialty Societies

Vanessa Caceres | December 1, 2008

The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies

Meet the HEP C Challenge

Dimitrios Vassilopoulos, MD, and Leonard H. Calabrese, DO | December 1, 2008

Keep a hepatitis C virus infection from hindering RA treatment

Cellular Therapy of Autoimmune Disease

Alan Tyndall, MD | November 1, 2008

Is a novel treatment breakthrough on the horizon?

Rheum to Learn

Terry Hartnett | October 1, 2008

The ARHP’s new NP/PA rheumatology training program will provide a boost to the workforce

Antiphospholipid Syndrome

From the College | August 1, 2008

Antiphospholipid syndrome (APS) is an autoimmune disease associated with frequent clotting in arteries and veins and fetal losses. The clotting results from the presence of proteins in the blood—called antiphospholipid autoantibodies (aPL)—formed against the person’s own tissues.